Dictaphone intensifies focus on health IT with sale of electronic manufacturing division to Bulova

Dictaphone Corp. announced this week the sale of its Electronic Manufacturing Systems (EMS) Division to Bulova Technologies, LLC.
   
Dictaphone's sale of its EMS Division unit is part of the company's continuing strategy to create a company focused principally on the healthcare information technology market. The sale follows the company's recent divestiture of its CRS Communications Recording Systems business, which involved the assembly of more hardware-intensive communications recording systems within the company's EMS facility, Dictaphone said.
   
"The sale of our Electronic Manufacturing Services (EMS) Division continues our strategy to focus on speech recognition and related voice and data technologies within the healthcare IT market, where we have experienced strong growth and developed an industry-leading product portfolio," said Rob Schwager, Chairman and CEO, Dictaphone Corp. "I am pleased that our Electronic Manufacturing Services (EMS) Division has found a good home with an industry leader such as Bulova Technologies."

Dictaphone EMS will be acquired through a wholly owned subsidiary, Bulova Technologies EMS LLC.

For Bulova's part, the acquisition represents the combination of the two organizations that will provide a natural complement for each other, said Bulova President and CEO Stephen L. Gurba. EMS complements Bulova Technologies' core strength in contract manufacturing and provides additional depth of management, added Gurba.

Dictaphone EMS, which now employs nearly 340 people is located in Melbourne, Fla., and is currently engaged in the contract manufacturing of sophisticated electronic products for a variety of well-known companies.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.